Inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by 11 different ketolide antibiotics

Current Microbiology

Volumn 37, Issue 6, 1998, Pages 418-425

  Champney, W Scott ^a   Tober, Craig L ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; HMR 3004; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; GENE EXPRESSION REGULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RIBOSOME SUBUNIT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRUCTURE ACTIVITY RELATION; TRANSLATION REGULATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; GENE EXPRESSION; PROTEIN BIOSYNTHESIS; RIBOSOMAL PROTEINS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); POSIBACTERIA; PROKARYOTA; STAPHYLOCOCCUS AUREUS;

EID: 0031726738     PISSN: 03438651     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002849900403     Document Type: Article

References (34)

1. Agouridas C, Benedetti Y, Denis A, Fromentin C, D' Ambrieres SG, Martret OL, Chantot JF (1994a) Ketolides: a new distinct semisynthetic class of macrolides. Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy: 227
2. Agouridas C, Collette P, Mauvias P, Chantot JF (1994b) Ketolides, a new destinct semi-synthetic class of macrolides: studies on the mechanism of action. Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy: 227
3. Agouridas C, Bonnefoy A, Chantot JF (1997a) In vitro antibacterial activity of HMR 3647, a novel ketolide highly active against respiratory pathogens. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 165
4. Agouridas C, Bonnefoy A, Chantot JF (1997b) In vivo antibacterial activity of HMR 3647, a novel ketolide highly active against respiratory pathogens. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 198
5. Anderson M, Bergeron J, Masamune H, Norcia M, Retsema J, Sutcliffe J (1995) Activity of CP-227,182, a des-cladinose 3 keto clarithromycin derivative, in cell free peptide synthesis and ribosome binding studies. Abstracts Frontiers of Translation Conference: 145
6. Bigot CM, Deere D, Muller C, Salgado E, Bergogne-Berezin E (1997) In vitro activity of a novel ketolide antimicrobial agent HMR3647 compared to erythromycin (ery), roxithromycin (rox), azithromycin (azi) and clarithromycin (cla). Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 166
7. B resistance phenotype. J Antimicrobial Chemother 40:85-90
8. Champney WS, Burdine R (1995) Macrolide antibiotics inhibit 50S ribosomal subunit assembly in Bacillus subtilis and Staphylococcus aureus. Antimicrobial Agents Chemother 39:2141-2144
9. Champney WS, Burdine R (1996) 50S Ribosomal subunit synthesis and translation are equivalent targets for erythromycin inhibition in Staphylococcus aureus. Antimicrobial Agents Chemother 40:1301-1303
10. Champney WS, Burdine R (1998a) Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells. Microbial Drug Resist (in press)
11. Champney WS, Burdine R (1998b) Azithromycin and clarithromycin inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells. Current Microbiol 36:119-123
12. Champney WS, Tober CL, Burdine R (1998) A comparison of the inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by nine different macrolide antibiotics. Current Microbiol (in press)
13. Ednie LM, Jacobs MR, Appelbaum PC (1997) Comparative antianaerobic activities of the ketolides HMR 3647 (RU66647) and HMR 3004 (RU 64004). Antimic Agents Chemother 41:2019-2022
14. Felmingham D, Robbins MJ, Leakey A, Cooke R, Dencer C, Salman H, Ridgway GL, Gruneberger RN, Bryskier A (1997) The comparative in vitro activity of HMR3647, a ketolide antimicrobial, against clinical bacterial isolates. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 166
15. Hardy DJ, Hensey DM, Beyer JM, Vojtko C, McDonald E, Fernandes PB (1988) Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimic Agents Chemother 32:1710-1719
16. Jett BD, Hatter KL, Huycke M, Gilmore MS (1997) Simplified agar plate method for quantifying viable bacteria. BioTech 23:648-650
17. Kirst HA (1993) Semi-synthetic derivatives of erythromycin. Prog Med Chem 30:57-88
18. Kitzis MD, Goldstein FW, Bismuth R, Meigi M, Acar JF (1997) Comparative in vitro activity of HMR3647, a new ketolide antibiotic, against S. aureus (SA) and coagulase negative staphylococci (CNS). Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 165
19. Levitt M, Perutz MF (1988) Aromatic rings act as hydrogen bond acceptors. J Mol Biol 201:751-754
20. Malathum K, Coque T, Singh KV, Murray BE (1997) Studies of a new ketolide, HMR3647, against multi-resistant gram-positive cocci. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 165
21. Mao JC-H, Putterman M (1969) The intermolecular complex of erythromycin and the ribosome. J Mol Biol 44:347-361
22. Miller JH (1972) Experiments in molecular genetics. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory
23. Nakayama I (1984) Macrolides in clinical practice. In: Omura S (ed) Macrolide antibiotics. Orlando, PL: Academic Press, pp 261-300
24. National Committee for Clinical Laboratory Standards (1993) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova, PA: NCCLS
25. Pankuch GA, Visalli MA, Jacobs MR, Appelbaum PC (1998) Susceptibilities of penicillin-and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU66647), a new ketolide, compared with susceptibilities fo 19 other agents. Antimic Agents Chemother 42:624-630
26. Phan LT, Or YS, Spina KP, Chen Y, Tufano M, Chu DTW, Nilius AM, Bui M-H, Plattner JJ (1997a) Tricyclic ketolides: monosubstitution on the imine ring. Synthesis and in vitro antibacterial activity. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 190
27. Phan LT, Or YS, Spina KP, Chen Y, Tufano M, Chu DTW, Nilius AM, Bui M-H, Plattner JJ (1997b) Tetracyclic ketolides: new antibacterial macrolides. Synthesis and in vitro antibacterial activity. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 190
28. Rosato A, Vicarini H. Bonnefoy A, Chantot JF, Leclercq R (1997) A non-inducer ketolide, HMR3004 (RU64004), active against streptococci inducibly cross-resistant to macrolides and lincomycin. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 58
29. Saenger W (1984) Principles of nucleic acid structure. New York: Springer-Verlag
30. Schulin T, Wennersten CB, Moellering RC, Eliopoulos GM (1997) In vitro activity of HMR3647 in comparison with erythromycin A against gram-positive bacteria. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 165
31. Weisblum B (1995) Erythromycin resistance by ribosome modification. Antimic Agents Chemother 39:577-585
32. Williams JD, Sefton AM (1993) Comparison of macrolide antibiotics. J Antimic Chemother 31, (Suppl. C): 11-26
33. Wise R, Andrews JM (1997) The in vitro activity of the new ketolide HMR3647 against a wide range of clinical isolates. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy: 165
34. Zuckerman JM, Kaye KM (1995) The newer macrolides. Azithromycin and clarithromycin. Infect Dis Clin N Am 9:731-745